Dongbang Medical Co., Ltd (KOSDAQ:240550)

Market Cap	116.81B -34.1%
Revenue (ttm)	125.12B +15.5%
Net Income	16.12B +72.8%
EPS	765.27 +50.1%
Shares Out	20.93M
PE Ratio	7.29
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	67,367
Open	5,410.00
Previous Close	5,460.00
Day's Range	5,340.00 - 5,600.00
52-Week Range	4,500.00 - 9,130.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Dongbang Medical

Dongbang Medical Co., Ltd produces and sells medical devices, fillers, bio medical devices, and cosmetics devices in South Korea. It offers HA filler, a medical device used for improving facial wrinkles and volume recovery under the ELASTY GRAND, ELASTY DEEP PLUS, ELASTY G PLUS, ELASTY D PLUS, and ELASTY F PLUS names; threads under the ELASTY LINE, ELASTY MESHFILL, ELASTY-V BARB, ELASTY-V UP, ELASTY-V SCREW, and ELASTY-V MONO names; and cannula, needle, and syringe products. The company also provides Hyaluronic acid mask, Beta-Glucan mask, FILL...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1985
• Employees: 274
• Stock Exchange: KOSDAQ
• Ticker Symbol: 240550

Financial Performance

In 2025, Dongbang Medical's revenue was 113.54 billion, an increase of 8.01% compared to the previous year's 105.11 billion. Earnings were 11.70 billion, an increase of 301.58%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 13, 2026

Data Sources Report a data error